Aclarion Inc
NASDAQ:ACON

Watchlist Manager
Aclarion Inc Logo
Aclarion Inc
NASDAQ:ACON
Watchlist
Price: 6.14 USD -11.59%
Market Cap: 4.1m USD

Aclarion Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Aclarion Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Aclarion Inc
NASDAQ:ACON
Free Cash Flow
-$5.6m
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Free Cash Flow
$1.4B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
38%
Inspire Medical Systems Inc
NYSE:INSP
Free Cash Flow
$98.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Free Cash Flow
$266.7m
CAGR 3-Years
30%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Free Cash Flow
$93.8m
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
19%
W
Waystar Holding Corp
NASDAQ:WAY
Free Cash Flow
$142.5m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aclarion Inc
Glance View

Market Cap
4.1m USD
Industry
Health Care

Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.

ACON Intrinsic Value
Not Available

See Also

What is Aclarion Inc's Free Cash Flow?
Free Cash Flow
-5.6m USD

Based on the financial report for Dec 31, 2024, Aclarion Inc's Free Cash Flow amounts to -5.6m USD.

What is Aclarion Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-31%

Over the last year, the Free Cash Flow growth was -49%. The average annual Free Cash Flow growth rates for Aclarion Inc have been -31% over the past three years .

Back to Top